MS vs MET
By Alex · Tickerpine
Morgan Stanley vs MetLife, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | MET |
|---|---|---|
| Price | $212.03 | $85.95 |
| Market cap | $334.43B | $55.30B |
| P/E ratio | 19.2 | 16.6 |
| ROE | 16.39% | 13.01% |
| Profit margin | 24.75% | 4.67% |
| Revenue growth | 16.30% | 2.70% |
| Dividend yield | 1.89% | 2.76% |
| Beta | 1.22 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs MET in plain English
- MS is the bigger company — about 6.0× the market cap of MET.
- MET is cheaper on earnings (P/E 16.6 vs 19.2).
- MS earns a higher return on equity (16% vs 13%).
- MS is growing revenue faster (16% vs 3%).
- MET has the higher dividend yield (2.76% vs 1.89%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
MET return calculator
See what $1,000 in MetLife, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.